WhiteBSnyderHSPatelMVB. Evaluation of medications used for hospitalized patients with sleep disturbances: a frequency analysis and literature review. J Pharm Pract. 2021. doi:10.1177/08971900211017857.
AltınyazarVKiyliogluN. Insomnia and dementia: is agomelatine treatment helpful? Case report and review of the literature. Therapeutic Advances in Psychopharmacology. 2016;6(4):263-268. doi:10.1177/2045125316646064.
4.
SateiaMJWinter-RosenbergSherrillCHealdJL, et al.Payer perspective of the American academy of sleep medicine clinical practice guideline for the pharmacologic treatment of chronic insomnia. Journal of Clinical Sleep Medicine. 2017;13(2):155-157. doi:10.5664/jcsm.6428.
5.
JantoKPrichardJRPusalavidyasagarS. An update on dual orexin receptor antagonists and their potential role in insomnia therapeutics. Journal of Clinical Sleep Medicine. 2018;14(8):1399-1408. doi:10.5664/jcsm.7282.
6.
AlvesMNarcisoMRFonsecaTGorjão ClaraJ. Letter to the editor regarding the article: “inappropriate prescribing to elderly patients in an internal medicine ward”. Acta Med Port. 2019;32(3):249. doi:10.20344/amp.12078.
7.
DiasATeixeira-LopesFMirandaA, et al.Comorbidity burden assessment in older people admitted to a Portuguese University Hospital. Aging Clin Exp Res. 2015;27(3):323-328. doi:10.1007/s40520-014-0280-5.